Therapeutic angiogenesis. The present and the future

Arquivos Brasileiros de Cardiologia

Volumn 78, Issue 2, 2002, Pages 145-147

  Ferreira, Alexandre Cesar ^a,b  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ANGINA PECTORIS; ANGIOGENESIS; CLINICAL TRIAL; EDITORIAL; GENE TARGETING; GENETIC TRANSFECTION; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE;

EID: 0036193692     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0066-782X2002000200001     Document Type: Editorial

References (17)

1. Amant C, Berthou L, Walsh K. Angiogenesis and gene therapy in man: dream or reality. Drugs 1999; 59: 33-6.
2. Isner, JM. Therapeutic angiogenesis: a new frontier for vascular therapy. Vasc Med 1996; 1: 79-87.
3. Banga JD. Therapeutic angiogenesis through intramuscular injection of the gene for vascular endothelial growth factor. Ned Tijdschr Geneeskd 2000; 144: 113-6.
4. Veikkola T, Alitalo K. VEGF receptors and angiogenesis. Semin Cancer Biol 1999; 3: 211-20.
5. Carmeliet P, Collen D. Molecular basis of angiogenesis: role of VGEF and VE-cadherin. Ann NY Acad Sci 2000; 902: 249-62.
6. Zachary I, Mathur A, Yla-Herttula S, Martin J. A novel non-angiogenic cardiovascular role for vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 2000; 20: 1512-20.
7. Isner JM. Angiogenesis: a breakthrough technology in cardiovascular medicine. J Invas Cardiol 2000; 12(SupplA): 1A-17A.
8. Rosengart TK, Lee LY, Patel SR, et al. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 1999; 100: 468-74.
9. Losordo DW, Pickermo JG, Takeshita S. Use of the rabbit ear artery serially assess foreign protein secretion after site specific arterial gene transfer in vivo: evidence that anatomic identification of successful gene transfer may underesti-mate the potential magnitude of transgene expression. Circulation 1994; 89: 785-92.
10. Losordo DW, Vale PR, Symes JF, et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct intramyocardial injection of phVEGF 165 as sole therapy for myocardial ischemia. Circulation 1998; 98: 2800-4.
11. Bauters C, Asahara T, Zheng LP, et al. Site specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surgery 1995; 21: 314-24.
12. Kornowski R, Fuchs S, Leon MB, Epstein SE. Delivery strategies achieve therapeutic myocardial angiogenesis. Circulation 2000; 101: 454-8.
13. Vale PR, Losordo DW, Milliken CE, Isner JM. Left ventricular electromechanical mapping to assess efficacy of phVEGF 165 gene transfer for therapeutic angiogenesis in chronic myocardial ischemia: angiogenesis. Circulation 2000; 102: 965-74.
14. Laham RJ, Post M, Sellke FW, Simeans M. Therapeutic angiogenes using local perivascular and pericardial delivery. Curr Interv Cardiol Rep 2000; 2: 213-7.
15. Laham RJ, Rezaee M, Poest M, et al. Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic ischemia. J Pharmacol Exp Ther 2000; 292: 795-802.
16. Baumgartner I. Therapeutic angiogenesis: theoretic problems using vascular endothelial growth factor. Curr Cardiol Rep 2000; 2: 24-8.
17. Saaristo A, Karpanen T, Alitalo K. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. Oncogene 2000; 199: 6122-9.